Less Common but Important Risks Some patients notice cosmetic changes such as facial fat loss, sometimes referred to online as Ozempic face, or temporary hair shedding during rapid weight loss
In clinical trials, retatrutide has been administered as a subcutaneous injection meaning it is injected into the fatty tissue just beneath the skin once weekly
Furthermore, the weight loss effect of GLP-/GIP dual agonists is achieved by combining an increase in energy expenditure with a decrease in food intake [130], and its potential in the treatment of obesity has been validated in clinical trials
[DOI] [PubMed] [Google Scholar] 28.Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials
GLP-1 Safety in RA So far, GLP-1 receptor agonists appear to be generally safe in people with RA, though more research is needed, says Nancy Lane, MD, an endowed professor of medicine, rheumatology, and aging research at the University of California in Davis
Rubino, M
